Research location
Colton
California, United States
Advertisement
Research activity in Colton
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 30 trials and 30 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Colton
30 linked trials · page 1 of 1Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsNCT06559306 · 2024-07-25 · 1 site observation
RECRUITING
ABO Blood Group Type Association With COVID-19 SeverityNCT05859958 · 2022-11-10 · 1 site observation
COMPLETED
Open-label Extension for Phase 3 Clinical Trials of SimufilamNCT05575076 · 2022-11-07 · 1 site observation
TERMINATED
Simufilam 100 mg for Mild-to-Moderate Alzheimer's DiseaseNCT04994483 · 2021-11-03 · 1 site observation
COMPLETED
Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 InfectionNCT05897528 · 2021-10-14 · 1 site observation
COMPLETED
Bryostatin Treatment of Moderately Severe Alzheimer's DiseaseNCT04538066 · 2020-08-30 · 1 site observation
COMPLETED
A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®NCT03892889 · 2019-04-29 · 1 site observation
TERMINATED
A Study to Test if TV-46000 is Safe for Maintenance Treatment of SchizophreniaNCT03893825 · 2019-04-17 · 1 site observation
COMPLETED
The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneNCT03739203 · 2018-11-10 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneNCT03738215 · 2018-11-09 · 1 site observation
COMPLETED
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 SignalingNCT03412643 · 2018-05-14 · 1 site observation
UNKNOWN
Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With SchizophreniaNCT03503318 · 2018-04-27 · 1 site observation
COMPLETED
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or PlaceboNCT03281954 · 2017-12-19 · 1 site observation
ACTIVE_NOT_RECRUITING
A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's DiseaseNCT02956486 · 2016-10-20 · 1 site observation
TERMINATED
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.NCT02788513 · 2016-08-11 · 1 site observation
COMPLETED
Chronic Hypertension and Pregnancy (CHAP) ProjectNCT02299414 · 2015-06-01 · 1 site observation
COMPLETED
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 StudyNCT02218008 · 2014-07-01 · 1 site observation
COMPLETED
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)NCT01688037 · 2012-09-01 · 1 site observation
COMPLETED
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension StudyNCT01436175 · 2012-02-27 · 1 site observation
TERMINATED
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderNCT01435759 · 2011-05-31 · 1 site observation
COMPLETED
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health OrganizationsNCT01181960 · 2010-08-01 · 1 site observation
COMPLETED
Comparison of Optimal Antipsychotic Treatments for Adults With SchizophreniaNCT00802100 · 2008-12-01 · 1 site observation
COMPLETED
International Study to Predict Optimised Treatment - in DepressionNCT00693849 · 2008-09-01 · 1 site observation
UNKNOWN
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective DisorderNCT00423878 · 2007-01-01 · 1 site observation
COMPLETED
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00333151 · 2006-05-01 · 1 site observation
COMPLETED
Insulin Resistance Intervention After Stroke TrialNCT00091949 · 2005-02-01 · 1 site observation
COMPLETED
Extension Study for 2993-112NCT01789957 · 2002-09-01 · 1 site observation
COMPLETED
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With MetforminNCT00039013 · 2002-03-01 · 1 site observation
COMPLETED
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a SulfonylureaNCT00039026 · 2002-02-01 · 1 site observation
COMPLETED
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast CancerNCT00003855 · 1999-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.